Remington G - Search Results

1

Clozapine exposure and the impact of smoking and gender: a population pharmacokinetic study.

Ng W, Uchida H, Ismail Z, Mamo DC, Rajji TK, Remington G, Sproule B, Pollock BG, Mulsant BH, Bies RR. Ng W, et al. Among authors: remington g. Ther Drug Monit. 2009 Jun;31(3):360-6. doi: 10.1097/FTD.0b013e31819c7037. Ther Drug Monit. 2009. PMID: 19349931

2

Prevalence of neuroleptic-induced dystonia in mania and schizophrenia.

Remington GJ, Voineskos G, Pollock B, Reed K, Coulter K. Remington GJ, et al. Am J Psychiatry. 1990 Sep;147(9):1231-3. doi: 10.1176/ajp.147.9.1231. Am J Psychiatry. 1990. PMID: 1974747

3

Acutely psychotic patients receiving high-dose haloperidol therapy.

Remington G, Pollock B, Voineskos G, Reed K, Coulter K. Remington G, et al. J Clin Psychopharmacol. 1993 Feb;13(1):41-5. J Clin Psychopharmacol. 1993. PMID: 8486816

4

Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6-[18F]-L-m-tyrosine.

Mamo D, Remington G, Nobrega J, Hussey D, Chirakal R, Wilson AA, Baker G, Houle S, Kapur S. Mamo D, et al. Among authors: remington g. Synapse. 2004 May;52(2):153-62. doi: 10.1002/syn.20016. Synapse. 2004. PMID: 15034921

5

A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.

Mamo D, Kapur S, Shammi CM, Papatheodorou G, Mann S, Therrien F, Remington G. Mamo D, et al. Among authors: remington g. Am J Psychiatry. 2004 May;161(5):818-25. doi: 10.1176/appi.ajp.161.5.818. Am J Psychiatry. 2004. PMID: 15121646 Clinical Trial.

6

Predictors and markers of clozapine response.

Chung C, Remington G. Chung C, et al. Among authors: remington g. Psychopharmacology (Berl). 2005 May;179(2):317-35. doi: 10.1007/s00213-005-2174-x. Epub 2005 Feb 17. Psychopharmacology (Berl). 2005. PMID: 15717209 Review.

7

A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone.

Remington G, Mamo D, Labelle A, Reiss J, Shammi C, Mannaert E, Mann S, Kapur S. Remington G, et al. Am J Psychiatry. 2006 Mar;163(3):396-401. doi: 10.1176/appi.ajp.163.3.396. Am J Psychiatry. 2006. PMID: 16513859 Free article.

8

Adjunctive versus monotherapeutic treatment for schizophrenia: addressing antipsychotic side effects.

Hazra M, Mamo DC, Remington G. Hazra M, et al. Among authors: remington g. Am J Psychiatry. 2008 Mar;165(3):396-7; author reply 397-8. doi: 10.1176/appi.ajp.2007.07111738. Am J Psychiatry. 2008. PMID: 18316434 No abstract available.

9

Monthly administration of long-acting injectable risperidone and striatal dopamine D2 receptor occupancy for the management of schizophrenia.

Uchida H, Mamo DC, Kapur S, Labelle A, Shammi C, Mannaert EJ, Mann SW, Remington G. Uchida H, et al. Among authors: remington g. J Clin Psychiatry. 2008 Aug;69(8):1281-6. doi: 10.4088/jcp.v69n0811. J Clin Psychiatry. 2008. PMID: 18642974 Clinical Trial.

10

Clozapine and global cognition in schizophrenia.

Rajji TK, Uchida H, Ismail Z, Ng W, Mamo DC, Remington G, Pollock BG, Mulsant BH. Rajji TK, et al. Among authors: remington g. J Clin Psychopharmacol. 2010 Aug;30(4):431-6. doi: 10.1097/JCP.0b013e3181e69060. J Clin Psychopharmacol. 2010. PMID: 20631560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters